IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 401 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.90 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $15,535,000 | +88.8% | 191,384 | +25.8% | 0.02% | +58.3% |
| Q4 2018 | $8,227,000 | -48.7% | 152,186 | -51.1% | 0.01% | +20.0% |
| Q3 2018 | $16,050,000 | +180.3% | 311,182 | +126.5% | 0.01% | +42.9% |
| Q2 2018 | $5,726,000 | -5.2% | 137,413 | +0.3% | 0.01% | -12.5% |
| Q1 2018 | $6,042,000 | -10.4% | 137,067 | +2.3% | 0.01% | -11.1% |
| Q4 2017 | $6,741,000 | +0.7% | 134,007 | +1.4% | 0.01% | 0.0% |
| Q3 2017 | $6,697,000 | -12.6% | 132,094 | -12.3% | 0.01% | -18.2% |
| Q2 2017 | $7,664,000 | +44.8% | 150,656 | +14.4% | 0.01% | +37.5% |
| Q1 2017 | $5,293,000 | -10.6% | 131,656 | +6.3% | 0.01% | -11.1% |
| Q4 2016 | $5,922,000 | +49.8% | 123,810 | +14.7% | 0.01% | +28.6% |
| Q3 2016 | $3,954,000 | +40.1% | 107,906 | -11.0% | 0.01% | +40.0% |
| Q2 2016 | $2,823,000 | -38.7% | 121,204 | +6.6% | 0.01% | -37.5% |
| Q1 2016 | $4,606,000 | -32.8% | 113,727 | +2.8% | 0.01% | -38.5% |
| Q4 2015 | $6,851,000 | – | 110,630 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,541,046 | $126,557 | 6.89% |
| M28 Capital Management LP | 126,300 | $4,513,962 | 5.10% |
| Bellevue Group AG | 9,511,900 | $339,955,306 | 4.93% |
| Deep Track Capital, LP | 2,834,069 | $101,289,626 | 4.16% |
| BVF INC/IL | 2,560,761 | $91,521,598 | 3.35% |
| Sicart Associates LLC | 210,698 | $7,530,347 | 2.93% |
| Privium Fund Management B.V. | 182,773 | $6,532,307 | 2.19% |
| Camber Capital Management LP | 1,925,000 | $68,800 | 2.12% |
| Orbimed Advisors | 2,124,500 | $75,929,630 | 1.49% |
| SECTOR GAMMA AS | 146,441 | $5,233,801 | 1.27% |